Gennaro Calendo

5PUBLICATIONS
48CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 01, 2026
Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia.

|Jan 13, 2025
ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in Cancer.

Lora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi

|Jun 11, 2024
Association between gut microbiota and CpG island methylator phenotype in colorectal cancer.

Pyoung Hwa Park, Kelsey Keith, Gennaro Calendo

|Oct 23, 2023
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.

Ying Wang, Shan He, Gennaro Calendo

|Dec 27, 2022
Non-pathogenic microbiota accelerate age-related CpG Island methylation in colonic mucosa.

Ang Sun, Pyounghwa Park, Lauren Cole

Pageof 1

Frequent Collaborators

3 joint publications

Jozef Madzo

3 joint publications

Jean-Pierre J Issa

2 joint publications

Pyounghwa Park

2 joint publications

Kelsey Keith